Non-Small-Cell Lung Cancer

Developer: MedLearning2017

Category: Medical

63 installs

ratings

ASO Keyword Dashboard

Tracking 38 keywords for Non-Small-Cell Lung Cancer in Google Play

Developer: MedLearning2017 Category: medical

Non-Small-Cell Lung Cancer tracks 38 keywords (no keywords rank yet; 38 need traction). Key metrics: opportunity 69.4, difficulty 46.7.

Pathophysiology and medical treatment of non-small-cell lung cancer

Tracked keywords

0 ranked • 38 not ranking yet

Top 10 coverage

—

Best rank — • Latest leader —

Avg opportunity

69.4

Top keyword: natural

Avg difficulty

46.7

Lower scores indicate easier wins

Opportunity leaders

natural

Opportunity: 73.0 • Difficulty: 47.8 • Rank —

Competitors: 1,101
68.5
medical

Opportunity: 72.0 • Difficulty: 44.6 • Rank —

Competitors: 802
70.2
improved

Opportunity: 72.0 • Difficulty: 49.7 • Rank —

Competitors: 764
64.9
target

Opportunity: 72.0 • Difficulty: 45.4 • Rank —

Competitors: 920
65.9
cell

Opportunity: 72.0 • Difficulty: 45.3 • Rank —

Competitors: 859
66.2

Unranked opportunities

natural

Opportunity: 73.0 • Difficulty: 47.8 • Competitors: 1,101
medical

Opportunity: 72.0 • Difficulty: 44.6 • Competitors: 802
improved

Opportunity: 72.0 • Difficulty: 49.7 • Competitors: 764
target

Opportunity: 72.0 • Difficulty: 45.4 • Competitors: 920
cell

Opportunity: 72.0 • Difficulty: 45.3 • Competitors: 859

High competition keywords

whether

Total apps: 76,585 • Major competitors: 8,596

Latest rank: — • Difficulty: 58.0
various

Total apps: 74,125 • Major competitors: 9,464

Latest rank: — • Difficulty: 57.7
variety

Total apps: 49,032 • Major competitors: 7,236

Latest rank: — • Difficulty: 57.3
well

Total apps: 46,736 • Major competitors: 4,373

Latest rank: — • Difficulty: 54.1
look

Total apps: 41,657 • Major competitors: 5,419

Latest rank: — • Difficulty: 60.6

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
whether	67	100	58	83 76,585 competing apps Median installs: 31,919 Avg rating: 2.9	—	—	8,596 major competitor apps
medical	72	100	45	70 12,810 competing apps Median installs: 23,738 Avg rating: 2.6	—	—	802 major competitor apps
management	69	100	52	77 32,852 competing apps Median installs: 18,996 Avg rating: 2.5	—	—	2,393 major competitor apps
avoid	71	100	61	72 16,708 competing apps Median installs: 44,275 Avg rating: 2.9	—	—	2,344 major competitor apps
variety	68	100	57	80 49,032 competing apps Median installs: 47,792 Avg rating: 3.0	—	—	7,236 major competitor apps
program	71	100	47	73 19,009 competing apps Median installs: 26,294 Avg rating: 2.7	—	—	1,273 major competitor apps
various	67	100	58	83 74,125 competing apps Median installs: 40,134 Avg rating: 2.8	—	—	9,464 major competitor apps
continue	71	100	56	72 15,832 competing apps Median installs: 38,380 Avg rating: 2.9	—	—	1,661 major competitor apps
main	69	100	53	77 32,327 competing apps Median installs: 33,651 Avg rating: 2.8	—	—	3,349 major competitor apps
look	68	100	61	79 41,657 competing apps Median installs: 44,109 Avg rating: 3.0	—	—	5,419 major competitor apps
well	68	100	54	80 46,736 competing apps Median installs: 30,414 Avg rating: 2.7	—	—	4,373 major competitor apps
improved	72	100	50	65 6,318 competing apps Median installs: 41,324 Avg rating: 3.0	—	—	764 major competitor apps
system	69	100	58	78 39,167 competing apps Median installs: 26,677 Avg rating: 2.7	—	—	3,528 major competitor apps
natural	73	100	48	68 10,200 competing apps Median installs: 32,918 Avg rating: 2.9	—	—	1,101 major competitor apps
line	71	100	52	72 16,478 competing apps Median installs: 37,066 Avg rating: 2.9	—	—	2,088 major competitor apps
target	72	100	45	66 7,194 competing apps Median installs: 38,577 Avg rating: 2.9	—	—	920 major competitor apps
types	70	100	58	75 25,293 competing apps Median installs: 43,355 Avg rating: 2.8	—	—	3,118 major competitor apps
drive	66	100	71	72 16,035 competing apps Median installs: 109,910 Avg rating: 2.8	—	—	3,426 major competitor apps
attack	67	100	51	65 6,175 competing apps Median installs: 101,397 Avg rating: 3.2	—	—	1,314 major competitor apps
cell	72	100	45	66 7,467 competing apps Median installs: 30,501 Avg rating: 2.6	—	—	859 major competitor apps
known	71	100	50	72 16,435 competing apps Median installs: 28,619 Avg rating: 2.8	—	—	1,458 major competitor apps
cancer	69	100	29	46 505 competing apps Median installs: 25,430 Avg rating: 3.1	—	—	40 major competitor apps
treatment	72	100	40	62 4,390 competing apps Median installs: 23,216 Avg rating: 2.5	—	—	298 major competitor apps
ways	72	100	66	69 10,787 competing apps Median installs: 46,787 Avg rating: 3.2	—	—	1,603 major competitor apps
produce	71	100	44	61 3,609 competing apps Median installs: 38,090 Avg rating: 3.1	—	—	438 major competitor apps

App Description

Pathophysiology and medical treatment of non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) is 1 of 2 main types of lung cancer. It develops from epithelial cells that line the lung airways and sacs, some of which produce mucus that lubricates and protects the lung. Cancer cells use a variety of ways to avoid the body’s natural defense—the immune system—to continue to grow, invade, and spread. In various types of NSCLC, molecular interactions between PD-1 on our immune system’s T-cells and PD-L1 on cancer cells drive whether or not the body’s immune system will attack a cancer cell. This program will look at the cellular underpinnings of NSCLC, as well as agents—known as checkpoint inhibitors—that target PD-1 or PD-L1 for improved management of this condition.